期刊文献+

胃泌素释放肽及其受体预测小细胞肺癌远处转移的价值分析 被引量:2

Analysis of Gastrin-releasng peptide(GRP) and Its Receptor in Forecasting Metastasis of Small Cell Lung Cancer
下载PDF
导出
摘要 目的探讨小细胞肺癌肿瘤标志物与预后,远处转移的关系以及预测远处转移的价值。方法回顾性分析73例小细胞肺癌患者临床及病理资料,接受手术治疗者38例(52.1%),局部放疗者35例(47.9%)。用免疫组织化学法检测神经元特异性烯醇化酶(NSE)、胃泌素释放肽(GRP)、胃泌素释放肽受体(GRPR)的蛋白表达,结合肿瘤体积重新分级,分析其与小细胞肺癌患者预后、远处转移的关系。结果 NSE、GRP、GRPR蛋白在小细胞肺癌组织中的阳性表达率分别为71.2%、79.5%、75.3%,GRP与GRPR的表达存在相关性(P=0.000)。GRP、GRPR蛋白不同表达水平患者间的预后及远处转移差异均有统计学意义(P<0.05)。GRP与GRPR蛋白表达预测小细胞肺癌远处转移的敏感度均为71.4%,特异性分别为83.9%、90.3%。结论 GRP、GRPR是敏感度及特异性均较好的预测小细胞肺癌侵袭性及远处转移的重要指标。 Objective To investigate the relationship between tumor marker and prognosis and metastasis of patients with small cell lung cancer (SCLC) and to evaluate the value of tumor marker forecasting the metastasis. Methods Seventy-three patients with SCLC were retrospectively analyzed. Thirty-eight (52. l %) patients received surgery, and 35 (47. 9 % ) received local radiotherapy. All patients paraffinembedded tumor tissues were obtained and the expressions of NSE, GRP, and GRPR were checked by immunohistochemistry. Combined with tumor volumes, the expressions were re-classified and analyzed with progrosis and distant metastasis of patients with small cell lung cancer. Results The positive ex- pression rates of NSE, GRP and GRPR protein in small cell lung cancer were detected as 71.2%, 79.5%, and 75.3%, respectively, of all tumor specimens. The expression of GRP was correlated to that of GRPR significantly (P = 0. 000). The expression of GRP and GRPR were associated with patients' prognosis and metastasis significantly (P〈0. 05). The sensitivity of the expression of GRP and GRPR forecasting the metastasis was both 71.4%, and the specificity of them was 83. 9% and 90. 3, respective- ly. Conclusion GRP and GRPR may be an important tumor marker forecasting the invasion and metasta- sis of small-cell lung cancer.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2013年第7期682-687,共6页 Cancer Research on Prevention and Treatment
关键词 小细胞肺癌 预后 远处转移 神经元特异性烯醇化酶 胃泌素释放肽 胃泌素释放肽受体 Small cell lung cancer(SCLC) Prognosis Metastasis Neuron specific enolase(NSE) Gas-trin-releasing peptide(GRP) Gastrin-releaing peptide receptor(GRPR)
  • 相关文献

参考文献15

  • 1Rami-Porta R, Crowley JJ, Goldstraw P. The revised TNM staging system for lung cancer [J].Ann Thorac Cardiovasc Surg, 2009,15(1 ) :4-9.
  • 2许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1365
  • 3刘永,周恒根,黄继玲,戴萍,姚元虎,朱广迎.EP方案同步放化疗治疗58例局限期小细胞肺癌[J].现代肿瘤医学,2010,18(12):2396-2398. 被引量:12
  • 4陈桂园,王丽娟,蒋国梁,傅小龙,钱浩,赵森.加速超分割放疗加化疗治疗局限期小细胞肺癌临床Ⅱ期试验结果分析[J].中华放射肿瘤学杂志,2004,13(4):286-288. 被引量:3
  • 5Schneider J,Philipp M,Salewski L,etal. Pro-gastrin releasing peptide (ProGRP) and neuron specific enolase (NSE) in thera- py control of patients with small-cell lung caneer[J]. Clin Lab,2003,49(1-2):35-42.
  • 6Patel O, Shulkes A, Baldwin GS. Gastrin-releasing peptide and cancer [J]. Biochim Biophys Acta,2006,1766(1):23-41.
  • 7Van de Wiele C,Dumont F, van Belle S, et al. Is there a role for agonist gastrin-releasing peptide receptor radioligands in tumour imaging? [J].Nucl Med Commun,2001,22(1)75-15.
  • 8Levine L, Licci JA 3rd, Townsend CM Jr, et al. Expression of gastrin-releasing peptide receptors in endometrial cancer [J]. J Am Coll Surg,2003,196(6) :898-904.
  • 9Yamaguchi K, Abe K, Kameya T, et al. Production and molec- ular size heterogeneity of irnmunoreactive gastrin-releasing peptide in fetal and adult lungs and primary lung tumors[J]. Cancer Res, 1983,43 (8) : 3932-9.
  • 10Perona R. Cell signalling: growth factors and tyrosine kinase receptors [J]. Clin Transl Oncol,2006,8(2):77-82.

二级参考文献25

  • 1赵彤,朱梅刚,黄宗义,张亚历,张素娟,李梅芳.肺癌癌基因蛋白产物同步检测的对比分析[J].癌症,1995,14(1):13-15. 被引量:54
  • 2谷化平,冯和平,徐志勇,苏红.免疫组化在恶性黑色素瘤诊断中的作用[J].中国肿瘤临床,1996,23(8):599-600. 被引量:4
  • 3殷蔚伯,余子豪,徐国镇,等.肿瘤放射治疗学[M].北京:中国协和医科大学出版社,1999:991.
  • 4Johnson D.Mangement of small cell luny cancer,current state[J].Chest,1999,116(suppl):25-30.
  • 5Mickeo FaldumA,Metz T.Staging small cell lung cancer:veterans administration lung strdy group international association for the study of lung cancer what limits limited disease[J]? Lung Cancer,2002,37(3):271-276.
  • 6朱广迎.局限期小细胞肺癌同步放化疗中EP方案剂量递增临床Ⅰ期实验.北京放射肿瘤学术论坛,2008,8:3-3.
  • 7Turrisi AT 3rd,Kim K,Blum R,et al.Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer tredted concurrently with cisplatin and etoposide[J].N Engl J Med,1999,340(40):265-271.
  • 8Liengswangwong V,Bonner JA,Shaw EG,et al.Limited-stage small-cell lung cancer:patterns of intrathoracic recurrence and the implications for thoracic radiotherapy[J].J Clin Oncol,1994,12(3):496-502.
  • 9Bogart JA,Herndon JE 2nd,Lyss AP,et al.70Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage small-cell lung cancer:Analysis of CALGBS39808[J].Int J Radiat Biolphys,2004,59(2):460-468.
  • 10于金明,殷蔚伯,李宝生.肿瘤精确放射治疗学P12-18[J].山东科学技术出版社,2001:627.

共引文献1377

同被引文献18

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部